Fulgent Genetics awarded $99M contract by VA

Fulgent Genetics (FLGT) announced it has been awarded a five-year contract by the U.S. Department of Veterans Affairs, or VA, to provide hereditary cancer, pharmacogenetic and other genetic testing to Veterans. Fulgent has been periodically providing genetic testing services to the members of the VA since 2017. The award is for up to $99M over five years, including both hereditary cancer testing and pharmacogenetic testing.